Skip to main content
PMC home page
Gut logoLink to Gut
. 1979 Feb;20(2):158–162. doi: 10.1136/gut.20.2.158

Double-blind comparison of cimetidine and placebo in the maintenance of healing of chronic duodenal ulceration.

K D Bardhan, D M Saul, J L Edwards, P M Smith, S J Haggie, J H Wyllie, H L Duthie, I V Fussey
PMCID: PMC1419437  PMID: 372063

Abstract

Patients suffering from chronic duodenal ulceration were allocated at random to treatment with either cimetidine (400 mg twice daily) or matching placebo for six months. Before entry to the trial all patients were shown to have healed ulcers on endoscopy. Most of the patients had participated in a one-month trial of cimetidine during which their ulcers healed. The trial showed that four of 29 patients relapsed on maintenance treatment with cimetidine, which therefore did not confer complete immunity from relapse. However, cimetidine treatment was very much better than placebo treatment, on which 18 of 31 patients relapsed. Of the 22 patients who relapsed clinically, 20 were submitted to endoscopy and 19 of these were shown to have ulcerated again. Endoscopy at the end of the trial showed that ulcers had also redeveloped in five of 28 asymptomatic patients. Length of previous dyspeptic history had no bearing on the results of the trial but there was evidence that relapse on placebo was less likely if the ulcer had originally healed on a high dose of cimetidine. Clinical relapse was associated with worsening duodenitis. Symptoms, clinical observation, and laboratory tests showed no important abnormalities in the patients.

Full text

PDF
158

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bardham K. D., Blum A., Gillespie G., Larkworthy W., Mekel R., Moshal M., Smith P. M., Venables C. W., Van Tongeren J. H., Walan A. Long-term treatment with cimetidine in duodenal ulceration. Lancet. 1977 Apr 23;1(8017):900–901. doi: 10.1016/s0140-6736(77)91219-3. [DOI] [PubMed] [Google Scholar]
  2. Blackwood W. S., Maudgal D. P., Pickard R. G., Lawrence D., Northfield T. C. Cimetidine in duodenal ulcer. Controlled trial. Lancet. 1976 Jul 24;2(7978):174–176. doi: 10.1016/s0140-6736(76)92347-3. [DOI] [PubMed] [Google Scholar]
  3. Bodemar G., Walan A. Cimetidine in the treatment of active duodenal and prepyloric ulcers. Lancet. 1976 Jul 24;2(7978):161–164. doi: 10.1016/s0140-6736(76)92342-4. [DOI] [PubMed] [Google Scholar]
  4. Bodemar G., Walan A. Maintenance treatment of recurrent peptic ulcer by cimetidine. Lancet. 1978 Feb 25;1(8061):403–407. doi: 10.1016/s0140-6736(78)91200-x. [DOI] [PubMed] [Google Scholar]
  5. Gray G. R., Smith I. S., Mackenzie I., Gillespie G. Long term cimetidine in the management of severe duodenal ulcer dyspepsia. Gastroenterology. 1978 Feb;74(2 Pt 2):397–401. [PubMed] [Google Scholar]
  6. Gray G. R., Smith I. S., McKenzie I., Crean G. P., Gillespie G. Oral cimetidine in severe duodenal ulceration. A double-blind controlled trial. Lancet. 1977 Jan 1;1(8001):4–7. doi: 10.1016/s0140-6736(77)91650-6. [DOI] [PubMed] [Google Scholar]
  7. Gudmand-Høyer E., Jensen K. B., Krag E., Rask-Madsen J., Rahbek I., Rune S. J., Wulff H. R. Prophylactic effect of cimetidine in duodenal ulcer disease. Br Med J. 1978 Apr 29;1(6120):1095–1097. doi: 10.1136/bmj.1.6120.1095. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Hetzel D. J., Hansky P. J., Shearman D. J., Korman M. G., Hecker R., Taggart G. J., Jackson R., Gabb B. W. Cimetidine treatment of duodenal ulceration: short term clinical trial and maintenance study. Gastroenterology. 1978 Feb;74(2 Pt 2):389–392. [PubMed] [Google Scholar]
  9. Saunders J. H., Wormsley K. G. Long-term effects and after-effects of treatment of duodenal ulcer with metiamide. Lancet. 1977 Apr 9;1(8015):765–767. doi: 10.1016/s0140-6736(77)92954-3. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES